* Prophase Labs Inc PRPH.OQ PRPH.O is expected to show a
fall
in quarterly revenue when it reports results on March 15 for
the period ending December 31 2023
* The New York City-based company is expected to report a
51.0% decrease in revenue to $10.688 million from $21.83 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Prophase Labs Inc is for
a
loss of 26 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $15.50, above its last closing price of $4.80.
This summary was machine generated March 13 at 12:39 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)